Komori
Results1379HOKUTO CORPORATIONFood

Summary of Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending March 2027 [Japanese GAAP] (Consolidated)

For the interim period of the fiscal year ending March 2027, revenue increased 3.9% year on year, while operating profit rose significantly to ¥712 million. Meanwhile, interim net income attributable to owners of the parent declined 72.4% due to the反動 from insurance proceeds recorded in the same period of the previous fiscal year.

Worth reading
53Recurring
Scored from 5 of 6 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
3.9
% (year-on-year change in revenue)
Wording
Conditional
How definitive the wording is.

Results for this period

Interim period (second quarter)1 April 2026 to 30 September 2026ConsolidatedJapanese GAAP
Net Sales39,561Millions of yenYear on year +3.9%Progress 44.9%
Operating profit712Millions of yenProgress 9.8%
Ordinary income827Millions of yenYear on year +168.6%Progress 10.8%
Net income attributable to owners of the parent386Millions of yenYear on year -72.4%Progress 7.4%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share¥12.34
Financial position at period-end
Total assets117,026Millions of yen
of which net assets 64,953 Millions of yenEquity ratio 55.5%vs. prior year-end -1.6pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Segment revenueDomestic mushroom business 24,405 Millions of yen (YoY +4.9%), Overseas mushroom business 3,695 Millions of yen (YoY -3.4%), Processed Products Business 3,975 Millions of yen (YoY +3.6%), Chemicals Business 7,484 Millions of yen (YoY +4.8%)
Segment profitDomestic mushroom business 1,090 Millions of yen (YoY +240.2%), Overseas mushroom business 89 Millions of yen (YoY -80.0%), Processed Products Business 210 Millions of yen (YoY +19.9%), Chemicals Business 441 Millions of yen (YoY +67.4%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales88,100 Millions of yen (YoY +2.5%)
Operating profit7,260 Millions of yen (YoY +3.3%)
Ordinary income7,650 Millions of yen (YoY -6.6%)
Net income5,250 Millions of yen (YoY -25.1%)
Annual Dividend Forecast55 Yen → 62 Yen(+12.7%)
Factors Behind Changes in Business Performance

The domestic mushroom business reported higher revenue and profit, driven by firm mushroom prices, cost reductions, new customer development, area strategies and promotional measures. The processed products business benefited from growth in products for foodservice and deli operators and mail-order sales, while orders from existing users remained firm in the chemical products business following price revisions. The overseas mushroom business reported lower revenue and profit due to slower consumption and lower sales volumes in the United States following higher gasoline prices, as well as the impact of weather in Taiwan.

Disclosure regarding the going concern assumption

None

Change in accounting policy
基準改正に伴う変更 Noneそれ以外の変更 None見積りの変更 None修正再表示 None
Changes in the scope of consolidationNew 0 / Excluded 0 / Company name Not applicable
Material subsequent eventsNone
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of non-current assets 3 Millions of yen / Extraordinary loss Loss on disposal of fixed assets 0 Millions of yen
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingWhether applicable Yes / Subject person Analysts and institutional investors
Issued Shares at Period-End33,359,040 Shares
Treasury Shares at Period-End1,957,585 Shares
Results for this period
ItemDetails
Fiscal Period ClassificationInterim period (second quarter)
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered1 April 2026 to 30 September 2026
Net Sales39,561 Millions of yen (YoY +3.9%)
Operating profit712 Millions of yen
Ordinary income827 Millions of yen (YoY +168.6%)
Profit attributable to owners of the parent386 Millions of yen (YoY -72.4%)
Net income per share¥12.34
Equity ratioEnd of the current fiscal period 55.5 / End of previous period 57.1
Total assets117,026 Millions of yen
Net assets64,953 Millions of yen
Full-year earnings forecastNet Sales 88,100 Millions of yen (YoY +2.5%) / Operating profit 7,260 Millions of yen (YoY +3.3%) / Ordinary income 7,650 Millions of yen (YoY -6.6%) / Net income 5,250 Millions of yen (YoY -25.1%)
Annual Dividend Forecast55 Yen → 62 Yen(+12.7%)
Segment revenueDomestic mushroom business 24,405 Millions of yen (YoY +4.9%), Overseas mushroom business 3,695 Millions of yen (YoY -3.4%), Processed Products Business 3,975 Millions of yen (YoY +3.6%), Chemicals Business 7,484 Millions of yen (YoY +4.8%)
Segment profitDomestic mushroom business 1,090 Millions of yen (YoY +240.2%), Overseas mushroom business 89 Millions of yen (YoY -80.0%), Processed Products Business 210 Millions of yen (YoY +19.9%), Chemicals Business 441 Millions of yen (YoY +67.4%)
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of non-current assets 3 Millions of yen / Extraordinary loss Loss on disposal of fixed assets 0 Millions of yen
Disclosure regarding the going concern assumptionNone
Change in accounting policyChanges due to revisions to standards None / Other changes None / Change in accounting estimate None / Restatement None
Changes in the scope of consolidationNew 0 / Excluded 0 / Company name Not applicable
Material subsequent eventsNone
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingWhether applicable Yes / Subject person Analysts and institutional investors
Issued Shares at Period-End33,359,040 Shares
Treasury Shares at Period-End1,957,585 Shares
Factors Behind Changes in Business PerformanceThe domestic mushroom business reported higher revenue and profit, driven by firm mushroom prices, cost reductions, new customer development, area strategies and promotional measures. The processed products business benefited from growth in products for foodservice and deli operators and mail-order sales, while orders from existing users remained firm in the chemical products business following price revisions. The overseas mushroom business reported lower revenue and profit due to slower consumption and lower sales volumes in the United States following higher gasoline prices, as well as the impact of weather in Taiwan.
Items this document does not state (12)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogDepreciation and amortizationImpairment loss

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

In the domestic mushroom business, mushroom prices remained firm, while cost reductions, new customer development, area strategies and promotions also contributed. In the processed products business, products for foodservice and deli operators and mail-order sales grew, while in the chemical products business, price revisions and orders from existing users remained firm. Meanwhile, the overseas mushroom business reported lower revenue and profit due to slower consumption and lower sales volumes in the United States following higher gasoline prices, as well as the impact of weather in Taiwan.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.